Lebrikizumab Biosimilar - Research Grade

Human

IL-13

5mg/ml

Human IgG4 S228P Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human IL-13. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Lebrikizumab.

Blue ice

Interleukin-13 (IL-13) is a Th2 cytokine driving allergic inflammation and tissue remodelling, and it is a central target in atopic-disease research. This research-grade antibody is an unconjugated, non-therapeutic analog of lebrikizumab that binds human IL-13 and is validated for functional assays. It is intended for research use only, purified to a low-endotoxin standard suitable for in vivo studies, and produced in scalable milligram to gram quantities for high-throughput laboratories. Applications include cytokine-neutralisation assays, Th2-signalling studies, in vitro screening, in vivo allergic-inflammation models, and biologics characterisation.

P35225

ICH3002

https://www.imgt.org/mAb-DB/